EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 96 filers reported holding EPIZYME INC in Q2 2022. The put-call ratio across all filers is 5.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -96.6% | 1,288 | -97.5% | 0.00% | – |
| Q1 2022 | $59,000 | -53.5% | 50,980 | -0.0% | 0.00% | – |
| Q4 2021 | $127,000 | -51.5% | 50,988 | -0.2% | 0.00% | – |
| Q3 2021 | $262,000 | -54.4% | 51,111 | -26.0% | 0.00% | -100.0% |
| Q2 2021 | $574,000 | -3.7% | 69,115 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $596,000 | -32.8% | 68,400 | -16.3% | 0.00% | 0.0% |
| Q4 2020 | $887,000 | -9.0% | 81,700 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $975,000 | -25.7% | 81,700 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $1,312,000 | +21.4% | 81,700 | +17.2% | 0.00% | 0.0% |
| Q1 2020 | $1,081,000 | -37.0% | 69,700 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,715,000 | +108.9% | 69,700 | -12.4% | 0.00% | +100.0% |
| Q3 2019 | $821,000 | -17.8% | 79,600 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $999,000 | +57.6% | 79,600 | +55.5% | 0.00% | 0.0% |
| Q1 2019 | $634,000 | +125.6% | 51,200 | +12.3% | 0.00% | – |
| Q4 2018 | $281,000 | -54.9% | 45,600 | -22.4% | 0.00% | -100.0% |
| Q3 2018 | $623,000 | -21.8% | 58,800 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $797,000 | -13.8% | 58,800 | +12.9% | 0.00% | 0.0% |
| Q1 2018 | $925,000 | +58.1% | 52,100 | +11.8% | 0.00% | 0.0% |
| Q4 2017 | $585,000 | -34.1% | 46,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $888,000 | +42.1% | 46,600 | +12.6% | 0.00% | 0.0% |
| Q2 2017 | $625,000 | -12.0% | 41,400 | -0.0% | 0.00% | 0.0% |
| Q1 2017 | $710,000 | +55.4% | 41,401 | +9.5% | 0.00% | 0.0% |
| Q4 2016 | $457,000 | +22.8% | 37,800 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $372,000 | -3.9% | 37,800 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $387,000 | -7.4% | 37,800 | +9.6% | 0.00% | 0.0% |
| Q1 2016 | $418,000 | -9.1% | 34,500 | +20.2% | 0.00% | 0.0% |
| Q4 2015 | $460,000 | -39.4% | 28,700 | -51.4% | 0.00% | 0.0% |
| Q3 2015 | $759,000 | -53.3% | 59,059 | -12.9% | 0.00% | -50.0% |
| Q2 2015 | $1,627,000 | +10.5% | 67,804 | -13.6% | 0.00% | 0.0% |
| Q1 2015 | $1,473,000 | – | 78,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |